SCHEDULE: Viking Global Updates Ownership Stake in Pharvaris N.V.
Schedule 13G Amendment
Viking Global Investors LP filed an amendment to its Schedule 13G, reporting a 5.6% beneficial ownership stake in Pharvaris N.V. following the retirement of David C. Ott.
Summary
- Viking Global Investors LP and associated entities maintain a beneficial ownership of 3,653,310 ordinary shares of Pharvaris N.V.
- The reported stake represents 5.6% of the total outstanding ordinary shares of the issuer.
- This filing serves as Amendment No. 4 to the original Schedule 13G.
- The update reflects the removal of David C. Ott as a reporting person due to his retirement from VGI and related entities effective March 31, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, administrative filing. It confirms the continued position of a major institutional investor while documenting a routine change in the firm's internal reporting structure.
Positives
- Institutional investor maintains a significant 5.6% stake, signaling continued interest in the company.
Negatives
- The filing reflects a change in leadership at the investment firm level, specifically the retirement of a key executive, David C. Ott.
Risks
- The investment is held for passive purposes and is not intended to influence the control of the issuer.
Future Outlook
The reporting persons certify that the securities were not acquired for the purpose of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that institutional ownership filings like Schedule 13G are standard regulatory requirements for major investors. This specific filing is administrative in nature, reflecting internal personnel changes at the investment firm rather than a change in investment strategy regarding the issuer.
Comparison to Industry Standards
- The filing adheres to standard SEC requirements for beneficial ownership reporting under the Securities Exchange Act of 1934.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Advisory Director of VGI and Executive Committee Member | David C. Ott | N/A | 03/31/2026 | Retirement |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reporting Person Removal | Removal of David C. Ott from the Schedule 13G filing group. | 03/31/2026 | Administrative change with no impact on the issuer's governance. |
Stakeholder Impact
- Shareholders may note the stability of the institutional position despite internal changes at the investment firm.
Next Steps
- Continued monitoring of future 13G or 13D filings for any changes in the reporting persons' position.
Key Dates
| Date | Description |
|---|---|
| 02/09/2021 | Date of authorization and designation letter for signatory. |
| 03/17/2026 | Date used for total ordinary shares outstanding calculation. |
| 03/31/2026 | Effective date of David C. Ott's retirement and the event requiring this filing. |
| 04/02/2026 | Date of the issuer's annual report on Form 20-F. |
| 05/15/2026 | Date of the filing and the Joint Filing Agreement. |
Keywords
Pharvaris, Viking Global Investors, Schedule 13G, Institutional Ownership, Biotech, Shareholder Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.